Related Experiment Video
Updated: May 9, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis Epidemiology and the Impact of the COVID-19 Pandemic on Tuberculosis Control in Tétouan, Morocco
Ayoub Ez-Zari1, Laila Farouk1, Nadya Mezzoug1
1Department of Biology, Laboratory of Biology and Health (UAE/U06FS), Abdelmalek Essaâdi University, Faculty of Science, Tetouan, MAR.
Introduction:
Tuberculosis (TB) is a major public health problem in Morocco, specifically in the Tangier-Tetouan-Al-Hoceima region, which includes the city of Tetouan. Although the improvement in the epidemiological situation in Tetouan over the past two decades, this remains insufficient to achieve the ultimate goal of eradicating tuberculosis. The present study describes and analyzes tuberculosis's epidemiological status in Tetouan between 2015 and 2022 to understand the evolution of infection, especially before and during the COVID-19 pandemic.
Methods:
A retrospective study was conducted on tuberculosis patients registered in Tetouan from January 2015 to December 2022. Data on demographic characteristics and clinical tuberculosis presentations were analyzed using IBM SPSS Statistics software (IBM Corp., Armonk, NY, USA), with significance determined at a p-value < 0.05.
Results:
A total of 6,397 TB cases were reported between 2015 and 2022, with an average incidence rate of 127.33 per 100,000 inhabitants. Males were more frequently affected, with a sex ratio of 1.64. The majority of cases occurred in young adults (15-34 years), with an average patient age of 39.69 years. New cases accounted for 5,751 (89.90%) of the total. Intra-pulmonary tuberculosis was the most common form, representing 3,612 cases (56.50%), of which 3,038 (88.39%) were bacteriologically confirmed. Among extra-pulmonary tuberculosis cases, pleural tuberculosis was the most prevalent, affecting 1,220 patients (43.79%). The cure rate was 5,236 (89.87%), while mortality remained below 3% (159 cases). The treatment dropout rate was 4.28% (249 cases). The COVID-19 pandemic led to a significant decline in TB notifications and an increase in the number of patients lost to follow-up.
Conclusion:
Despite the favorable epidemiological evolution of the disease in Tetouan, many efforts are essential for more case detection and to overcome the impact of the COVID-19 pandemic.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...